Osteoarthritis in the Tibiofemoral Joint

Article

Dr. Casey Kerrigan, Chair of Physical Medicine and Rehabilitation at UVA Health System, discusses osteoarthritis in the tibiofemoral joint and knee varus torque

In this online video from The Doctor's Channel, Casey Kerrigan, MD, MS, Department Chair, Professor of Physical Medicine and Rehabilitation, University of Virginia Health System, discusses osteoarthritis in the tibiofemoral joint and knee varus torque, which results in medial compartment osteoarthritis.

Click here to access this third-party resource.

Related Videos
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
© 2024 MJH Life Sciences

All rights reserved.